Export Target Market Javon Motley

EXPORT TARGET MARKET 2 Export Target Market Javon Motley The University of the Southern Mississippi ED 620 H001

This report aims to define the export markets for insulin from the United States on a global scale. It evaluates the conditions necessary for successful export strategies, considering market environment factors. The analysis emphasizes key criteria such as export volume, GDP per capita, insulin consumption rates, and population sizes across various countries. A decision matrix is employed to determine the most favorable markets for expansion, with Mexico, China, and Germany emerging as top targets based on weighted scores derived from these criteria. The approach includes collecting data from reputable sources and assigning appropriate weights to each criterion to facilitate informed decision-making. The goal is to optimize the export strategy for Humulin R by aligning it with market opportunities and trade relationships, ultimately expanding global reach and increasing sales. Considerations include trade relations, economic capacity, demand for insulin, and population demographics, which collectively influence the export potential of various countries. Regular assessment of these factors ensures adaptation to evolving market conditions and enhances the effectiveness of the export strategy.

Paper For Above instruction

The globalization of healthcare markets has created substantial opportunities for pharmaceutical companies to expand their reach beyond domestic borders. For insulin manufacturers like Humulin R, strategic export planning is critical for tapping into international markets characterized by rising diabetes prevalence, expanding healthcare infrastructure, and favorable trade relations. This paper examines the development of an effective export strategy for insulin from the United States, focusing on key market selection criteria, data analysis, and trade considerations.

Introduction

The global burden of diabetes mellitus has risen sharply over recent decades, with the International Diabetes Federation reporting over 537 million adults living with diabetes in 2021. This increasing prevalence signifies a corresponding rise in demand for insulin therapies worldwide. For U.S.-based insulin producers such as Humulin R, the export of insulin represents not only an economic opportunity but also a contribution to addressing global health disparities. To capitalize on this potential, companies must carefully select target markets based on multiple factors, including trade volume, economic capacity, disease prevalence, and population demographics.

Criteria for Market Selection

Effective market selection hinges on a multivariate analysis integrating quantitative and qualitative data. The criteria considered include:

• Export Volume: The total value of U.S. insulin exports to potential markets reflects existing trade relations and market receptiveness.
• GDP per Capita: Indicates consumer purchasing power and overall market size.
• Insulin Consumption Rate: The prevalence of diabetes and insulin usage per capita demonstrates demand potential.
• Population Size: Larger populations typically indicate higher absolute demand, though per capita factors are also vital.

To facilitate a comprehensive analysis, each criterion is assigned a weight; in this study, export volume accounts for 25%, GDP per capita 20%, insulin consumption 30%, and population 25%. This weighting reflects the relative importance of demand, economic capacity, and trade relations.

Data Collection and Methodology

The analysis utilizes trade data from sources such as Statista and the US International Trade Commission, alongside economic indicators from the World Bank. These data points form the basis for scoring countries in the decision matrix. Each country is evaluated across the criteria, scored, and weighted according to the predefined importance. Countries such as China, Mexico, Canada, Germany, Japan, the UK, the Netherlands, and the United States are analyzed to determine export feasibility. For illustrative purposes, the data suggests that Mexico, China, and Germany rank highest in weighted scores, indicating they are the most promising markets for U.S. insulin exports.

Findings and Implications

The analysis reveals that Mexico, China, and Germany possess favorable trade volumes, substantial GDP per capita, and high insulin consumption rates. Mexico's proximity to the U.S. and existing trade agreements bolster its position as the top target. China, with its large population and expanding healthcare system, offers significant growth potential. Germany's strong healthcare infrastructure and high per capita income make it a lucrative market as well. While other markets like Japan, the UK, and the Netherlands exhibit potential, their scores are comparatively lower due to trade volume or consumption rates.

Strategic Recommendations

Based on the decision matrix outcomes, the following strategic actions are recommended:

1. Prioritize market entry into Mexico, leveraging existing trade relations and logistics advantages.
2. Develop targeted marketing efforts for China, focusing on its vast population and emerging healthcare demands.
3. Establish collaborations with local distributors and healthcare providers in Germany to navigate regulatory environments effectively.
4. Monitor evolving healthcare policies and import regulations to adapt strategies dynamically.
5. Invest in localized branding and patient education initiatives to foster acceptance and demand.

Additionally, maintaining flexibility to reassess market conditions periodically ensures sustained growth and risk mitigation.

Conclusion

In conclusion, an effective export strategy for Humulin R requires a data-driven approach that considers multiple market factors. The weighted decision matrix illustrates that Mexico, China, and Germany are the most promising markets based on current data. By focusing resources and efforts on these countries, Humulin R can enhance its international footprint, improve patient access, and generate increased revenue. Continual market analysis and adaptation to regulatory and economic shifts will be vital for long-term success in the global insulin market.

References

• Alotaibi, M. B., & Zhang, Y. (2017). The relationship between export market orientation and export performance: An empirical study. Applied Economics.
• Garcàa, I. C., Bullà³n, F. M., Bueno, M. J., & Vicente, J. A. (2020). Exploring the exporting-downsizing link: Does the type of export strategy and firm efficiency in foreign markets matter? Journal of Business Research.
• Sitabutr, V., & Deebhijarn, S. (2017). Community-based enterprise export strategy success: Thailand’s OTOP branding program. Prague Development Center.
• Wang, W., & Ma, H. (2018). Export strategy, export intensity, and learning: Integrating the resource perspective and institutional perspective. Journal of World Business.
• U.S. International Trade Commission. (2020). Trade DataWeb. https://dataweb.usitc.gov
• Statista. (2020). Global insulin market data. https://statista.com
• World Bank. (2020). World Development Indicators. https://data.worldbank.org
• International Diabetes Federation. (2021). Diabetes Atlas, 9th edition. https://idf.org
• U.S. Department of Commerce. (2020). Export.gov: Market Reports. https://export.gov
• GATT/WTO. (2017). Trade policies and regulations. https://wto.org